ANDISSO T1200 Pro 12-Position Automated Transdermal Diffusion System
| Brand | ANDISSO |
|---|---|
| Origin | Shanghai, China |
| Manufacturer Type | Authorized Distributor |
| Origin Category | Domestic (China) |
| Model | T1200 |
| Pricing | Available Upon Request |
Overview
The ANDISSO T1200 Pro is a precision-engineered 12-position automated transdermal diffusion system designed for rigorous in vitro evaluation of percutaneous drug delivery and cosmetic formulation performance. It operates on the Franz diffusion cell principle—a standardized hydrodynamic configuration widely adopted in regulatory science for modeling passive diffusion across biological membranes. The system fully complies with United States Pharmacopeia Chapter <1724> “In Vitro Release Testing of Transdermal Delivery Systems,” ensuring methodological alignment with FDA-recognized protocols for IVRT (In Vitro Release Testing) and IVPT (In Vitro Permeation Testing). Its integrated dry-heating temperature control module maintains precise, uniform thermal conditions (typically 32 ± 0.5 °C) across all 12 stations—mimicking physiological skin surface temperature without introducing evaporation artifacts or condensation risks associated with water-jacketed systems. This architecture supports reproducible, low-drift diffusion kinetics essential for comparative formulation screening, stability-indicating release profiling, and regulatory submission packages.
Key Features
- 12 independent, parallel diffusion stations with individual temperature monitoring and feedback-controlled dry-heating modules
- Modified Franz-type diffusion cells featuring optimized donor–receiver compartment geometry, standardized 1.77 cm² effective diffusion area, and compliant membrane clamping mechanisms
- Programmable sampling intervals (e.g., 0.5, 1, 2, 4, 8, 12, 24 h) with automated fraction collector integration capability (via optional interface)
- Stainless-steel construction with corrosion-resistant surface finish for compatibility with organic solvents, surfactants, and pH-extreme media
- Real-time digital temperature display per station and system-level alarm for out-of-spec deviation (> ±1.0 °C)
- Modular design supporting interchangeable cell configurations (e.g., vertical vs. horizontal orientation) and membrane holder adaptors for human epidermis, pig ear skin, silicone membranes, and Strat-M® synthetic membranes
Sample Compatibility & Compliance
The T1200 Pro accommodates a broad spectrum of topical dosage forms including ointments, gels, creams, lotions, sprays, patches, and microneedle arrays. It enables method development under physiologically relevant conditions—using receptor media such as PBS (pH 7.4), isotonic saline, or ethanol/water mixtures—as specified in ICH Q5C and USP <1724>. All hardware components meet ISO 9001 manufacturing traceability requirements, and the system’s operational parameters are documented to support GLP-compliant study execution. When paired with validated analytical workflows (e.g., HPLC-UV or LC-MS/MS quantification), data generated satisfies regulatory expectations for bioequivalence assessment of generic transdermal products per FDA Guidance for Industry (2022) and EMA CHMP Assessment Report templates.
Software & Data Management
While the base T1200 Pro operates via intuitive front-panel controls, it is compatible with optional PC-based software (ANDISSO DiffusionSuite™ v3.2) that provides full audit trail functionality compliant with 21 CFR Part 11. The software logs user identity, timestamped parameter changes, temperature history per station, and sampling event records—including electronic signatures for protocol approval and report finalization. Raw concentration-time datasets export in CSV and Excel formats for PK modeling (e.g., zero-order, first-order, Higuchi, Korsmeyer-Peppas analysis) using industry-standard tools such as Phoenix WinNonlin® or GraphPad Prism®. All metadata adhere to ISA-Tab conventions for interoperability with laboratory information management systems (LIMS).
Applications
- Development and optimization of transdermal drug delivery systems (TDDS), including matrix-type and reservoir-type patches
- Comparative IVRT studies for generic product bioequivalence demonstration per FDA draft guidance
- Stability-indicating release testing across accelerated and long-term storage conditions
- Skin permeation barrier assessment of nanocarriers (liposomes, ethosomes, polymeric nanoparticles)
- In vitro safety profiling of cosmetic actives (e.g., retinoids, peptides, antioxidants) under OECD TG 428-aligned protocols
- Regulatory dossier preparation for NDA, ANDA, or CPNP submissions requiring USP <1724>-compliant data
FAQ
Does the T1200 Pro support both IVRT and IVPT protocols?
Yes—its adjustable receptor volume (typically 5–7 mL), standardized diffusion area, and temperature control enable strict adherence to both USP <1724> IVRT and IVPT method specifications.
Is membrane integrity verification integrated into the system?
No—membrane integrity testing (e.g., transepidermal water loss measurement or electrical resistance validation) must be performed separately prior to diffusion runs using external instrumentation.
Can the system be used with non-human skin membranes?
Yes—validated with porcine ear skin, human cadaver epidermis, and synthetic membranes including Strat-M®, Cellu-Derm™, and silicone RTV.
What documentation is provided for regulatory audits?
Each unit ships with Factory Acceptance Test (FAT) report, calibration certificate traceable to NIST standards, and a complete SOP template library aligned with ISO/IEC 17025 and ALAC requirements.
Is remote monitoring supported?
Not natively—but optional Ethernet-enabled controllers allow integration into facility-wide SCADA or LIMS networks via Modbus TCP or OPC UA protocols.
